Clinical Trials Browser

Phase 1 × Solid Tumor × Trastuzumab × Clear all

NCT03916094 2022-05-05

Evaluate Safety, Tolerability and Pharmacokinetics of HLX22 in Patients With Advanced Solid Tumors Overexpressing HER2

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT02593708 2017-11-17

Phase1 of Neratinib+Trastuzumab, Pertuzumab, Paclitaxel in Patients With Advanced Solid Tumors/HER2+

Phase 1 Terminated

Other solid neoplasm

Solid Tumor